146,644 Corteva, Inc. $CTVA Shares Bought by ZWJ Investment Counsel Inc.

ZWJ Investment Counsel Inc. grew its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 19.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 915,449 shares of the company’s stock after purchasing an additional 146,644 shares during the period. Corteva makes up 2.0% of ZWJ Investment Counsel Inc.’s portfolio, making the stock its 15th biggest holding. ZWJ Investment Counsel Inc.’s holdings in Corteva were worth $71,085,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CTVA. EFG International AG acquired a new stake in Corteva during the second quarter valued at approximately $25,000. Compass Financial Management LLC bought a new stake in Corteva during the second quarter worth approximately $25,000. Elevation Wealth Partners LLC boosted its holdings in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after buying an additional 261 shares in the last quarter. Clearstead Trust LLC bought a new stake in Corteva during the second quarter worth approximately $31,000. Finally, N.E.W. Advisory Services LLC acquired a new position in Corteva in the second quarter worth approximately $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.3%

NYSE:CTVA opened at $13.40 on Thursday. The firm has a market capitalization of $8.94 billion, a price-to-earnings ratio of 8.87, a PEG ratio of 1.87 and a beta of 0.57. Corteva, Inc. has a 1-year low of $11.74 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The business’s fifty day moving average price is $67.61 and its 200 day moving average price is $76.84.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The firm had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the business earned $2.20 EPS. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 1.04 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were issued a $0.18 dividend. The ex-dividend date was Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.4%. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on CTVA shares. Oppenheimer set a $17.00 price target on Corteva in a report on Monday, October 5th. Morgan Stanley reiterated an “overweight” rating and set a $18.00 price objective on shares of Corteva in a research report on Friday, October 2nd. Argus reissued a “buy” rating and set a $91.00 price objective on shares of Corteva in a research note on Friday, September 18th. JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price objective for the company in a research note on Tuesday, October 6th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 target price on shares of Corteva in a report on Monday, August 3rd. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $60.59.

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.